文献速递治疗药物监测与药物基因组学药物不良反应与药物警戒特殊人群用药

气候变化对癫痫患者用药的影响:复杂性与挑战

Medications, epilepsy and climate change: Added layers of complexity.
PubMed 文献 · Br J Clin Pharmacol · 2025-05-27

该综述聚焦气候变化对癫痫患者(PWE)用药的影响,尤其是抗癫痫发作药物(ASMs)、抗精神病药和抗抑郁药的药理特性。部分药物的理化稳定性实验显示高温和/或高湿度可影响卡马西平、丙戊酸、苯妥英或劳拉西泮,但临床结局研究非常有限。血样运输中的稳定性也需考虑,尤其对低收入国家患者。需紧急研究极端天气事件对药物稳定性、药代动力学及患者脆弱性的复杂交互影响。

要点

  • 卡马西平、丙戊酸、苯妥英或劳拉西泮的理化稳定性可能受高温和/或高湿度影响。
  • 血样运输至治疗药物监测单位时需考虑稳定性,尤其低收入国家患者。
  • 需研究热浪等极端天气事件对药物稳定性、药代动力学及患者脆弱性的交互影响。

核心结论

  • 气候变化可能通过影响药物理化稳定性等途径对癫痫患者的药物治疗带来额外复杂性,但临床结局证据非常有限。
  • 需紧急研究极端天气事件对药物稳定性、药代动力学与个体脆弱性、神经精神共病及地理挑战的复杂交互影响。

研究设计与样本

  • 综述,聚焦气候变化对癫痫患者所用抗癫痫发作药物、抗精神病药和抗抑郁药药理特性的潜在影响。

主要发现

  • 部分药物的理化稳定性实验显示,卡马西平、丙戊酸、苯妥英或劳拉西泮可能在高温和/或高湿度条件下受影响。
  • 针对临床结局效应的研究非常有限。
  • 血样在运输至治疗药物监测单位过程中的稳定性需考虑,尤其对低收入国家患者。

临床怎么用

  • 临床应关注高温、高湿度等环境条件对卡马西平、丙戊酸、苯妥英或劳拉西泮稳定性的潜在影响。
  • 运输至治疗药物监测单位的血样需考虑稳定性,尤其对基础设施薄弱地区的患者。

局限性

  • 临床结局效应的研究非常有限,多数证据来自理化稳定性实验。
  • 缺乏对极端天气事件下药物稳定性、药代动力学与个体脆弱性复杂交互的深入研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Climate change-the global crisis with pervasive health impacts-has adverse consequences for people with epilepsy (PWE) who have low quality of life due to poor seizure control, socioeconomic disadvantages and comorbidities. This review focuses on the potential effects of climate change on the pharmacological characteristics of antiseizure medications (ASMs), antipsychotics and antidepressants. We note that findings particularly obtained from physicochemical stability studies have been demonstrated experimentally for some specific environmental conditions whereas studies for clinical outcome effects are very limited. Carbamazepine, valproate, phenytoin or lorazepam appear to be ASMs at risk of being affected by high temperature and/or humidity. Even the stability of blood samples needs to be considered during transportation to therapeutic drug monitoring units, particularly for the PWE living in low-income countries that are facing the most challenges of climate change effects attributed to low infrastructure and healthcare system capacity. We need more urgent research investigating drug responses of PWE regarding especially the effects of adverse weather events such as heatwaves on physicochemical stability or pharmacokinetics of drugs in a complex interaction with the vulnerabilities of individuals, accompanying neuropsychiatric disorders and geographical challenges. Then we will be able to develop pharmacological treatment strategies to improve the quality of life of PWE during adverse weather events.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gulcebi MI, Gavas S, Sisodiya SM, et al. Medications, epilepsy and climate change: Added layers of complexity. Br J Clin Pharmacol. 2025. PMID: 40432167. doi:10.1002/bcp.70108

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。